Ex-Rad

Ex-Rad (or Ex-RAD; recilisib sodium (INN, USAN); development code ON 01210.Na) is an experimental drug being developed by Onconova Therapeutics and the U.S. Department of Defense. It is being studied as a radiation protection agent. Chemically, it is the sodium salt of 4-carboxystyryl-4-chlorobenzylsulfone.
Wikipedia contributors, "Ex-Rad", Wikipedia, revision 1329566234, retrieved 20 November 2026, source, CC BY-SA 4.0.